NEW YORK (GenomeWeb) – Brooks Automation announced Thursday afternoon that it has acquired UK-based scientific tools and consumables maker 4titude for $65 million in cash.
Brooks also said it has signed a seven-year, $200 million senior term loan agreement with a group of institutional investors, including Morgan Stanley Senior Funding, which is acting as administrative agent.
4titude sells a variety of life science consumables and instruments, including PCR and sequencing tubes, plates, and seals; assay plates; heat sealing instrumentation and materials; and liquid handling robotics. According to Brooks, the company has had 20 percent annual growth in the last two years, and generated roughly $14 million in revenues over the past 12 months.
"As our services have expanded into supporting the genomic analysis process for many of our storage customers, [with 4titude] we now have a premier consumables offering that gives our customers the sample quality and integrity they require in this high-growth application space," Brooks President Dusty Tenney said in a statement.
Additional terms of the acquisition were not disclosed.